Amyris Inc BioDisrupt 2019 Transcript
Good morning. So it's like we're -- it was great that Peter actually opened up the room and got everybody quiet. I've never seen a room go quiet this fast. And the hard thing about that is it is tough to open it back up again. So we'll work on that.
There is much to share this morning. So I'm going to jump in very quickly. It's probably a much more content-dense morning than I'd like it to be. But this is part of ensuring that we get as much information out quickly. So for my morning session, we're going to do 3 things: I'd like to do some introductions and some announcements, I'd like to cover some housekeeping matters so that we get out as much information as possible in the time that we have, and then a business update. And the business update will be probably a 15-minute overview of where we are for our business and the outlook for the year.
As I look around the room, there is about 30% of our ownership represented. And if I consider the owners that sit around our board table, that's a little over 70% of the owners of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |